← Open Payments lookup

OLUWATOYIN OTTUN: Open Payments

NPI 1790171296 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,013 in 50 payments from 16 companies in 2025. Trend: 2023 $81 · 2024 $682 · 2025 $1,013

Food & beverage: $1,013
CompanyPaymentsAmount
ABBVIE INC.16$171
Indivior Inc.4$116
Supernus Pharmaceuticals, Inc.5$103
Vanda Pharmaceuticals Inc.3$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$93
Teva Pharmaceuticals USA, Inc.3$80
Alkermes, Inc.3$61
Neurocrine BioSciences, Inc.2$57
E.R. Squibb & Sons, L.L.C.2$48
Janssen Pharmaceuticals, Inc2$39

Products named: VRAYLAR, SUBLOCADE, Qelbree, HETLIOZ, CAPLYTA, AUSTEDO XR, INGREZZA, COBENFY.

Industry payments across MD — which companies pay providers there.